Novel Smoking Cessation Drug for Schizophrenia

NCT02230384 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Smoking Cessation

Interventions

DRUG: Active JNJ Drug
DRUG: Placebo Pill

Sponsor

K.N. Roy Chengappa

Collaborators

[object Object]
[object Object]
[object Object]